Skip to main content

Table 2 Univariate and multivariate analyses for RFS and CSS

From: Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy

 

RFS

CSS

variables

5 yr. rate

p value

HR

95% CI

p value

5 yr. rate

p value

HR

95% CI

p value

size >4 cm

 

0.304

    

0.073

2.781

0.710–10.990

0.142

 no

92.0

    

93.9

    

 yes

83.1

    

87.9

    

SCC Ag

 

0.611

    

0.904

   

  ≤ 2 ng/mL

88.0

    

89.9

    

  > 2 ng/mL

86.9

    

91.2

    

DSI

 

0.985

    

0.778

   

 absent

86.4

    

90.7

    

 present

87.9

    

90.6

    

LVSI

 

0.671

    

0.720

   

 absent

100.0

    

100.0

    

 present

86.9

    

90.1

    

PM invasion

 

0.145

    

0.196

   

 absent

85.7

    

89.2

    

 present

100.0

    

100.0

    

RM

 

0.052

2.868

0.881–9.333

0.080

 

0.132

   

 clear

92.8

    

92.7

    

 close or positive

81.0

    

88.0

    

LN metastasis

 

0.664

    

0.932

   

 absent

88.8

    

88.2

    

 present

87.3

    

91.1

    

No. of positive LN

 

0.021

3.179

1.066–9.477

0.038

 

0.005

4.004

1.130–14.195

0.032

 0–2

92.8

    

94.5

    

  ≥ 3

74.1

    

81.5

    

LNR

 

0.018

2.330

0.611–8.879

0.215

 

0.011

1.740

0.391–7.740

0.467

  < 0.25

90.7

    

91.8

    

  ≥ 0.25

63.6

    

81.8

    

No. of risk factors

 

0.299

    

0.345

   

 1

90.8

    

90.7

    

 2–3

81.3

    

90.6

    
  1. RFS recurrence free survival rate, CSS cancer specific survival rate, HR hazard ratio, CI confidence interval, SCC Ag squamous cell carcinoma antigen, DSI deep stromal invasion, LVSI lymphovascular space invasion, PM parametrium, RM resection margin, LN lymph node, LNR lymph node ratio